Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance

BACKGROUND: Daily trimethoprim-sulfamethoxazole (TS) protects against malaria, but efficacy may be diminished as anti-folate resistance increases. This study assessed the incidence of falciparum malaria and the prevalence of resistance-conferring Plasmodium falciparum mutations in HIV-infected child...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gasasira, Anne F, Kamya, Moses R, Ochong, Edwin O, Vora, Neil, Achan, Jane, Charlebois, Edwin, Ruel, Theodore, Kateera, Fredrick, Meya, Denise N, Havlir, Diane, Rosenthal, Philip J, Dorsey, Grant
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903607/
https://ncbi.nlm.nih.gov/pubmed/20573194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-9-177
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars